Editors’ Choice: Top Stories of 2025
About this episode
The GEN team reflects on impactful stories from 2025, discussing AI in drug discovery, cell and gene therapy, and biotech developments in Africa.
In the final episode of 2025, the GEN team came together to reflect on some of the stories over the last year that they each found impactful. Some of the stories were covered in GEN ’s December issue, but our editors took the time to discuss some topics in a bit more depth during the podcast. The discussion began with an update on the progress of AI use in drug discovery. Cell and gene therapy was a big topic with the positive outcome for Baby KJ, while Sarepta dealt with a rollercoaster of a year with their DMD treatment, Elevidys. Research and biotech in Africa are growing and the discussion ranged from challenges to promise in research and development on the continent. This year’s NIH budget cuts and impacted institutions rounded out the conversation. Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, Phd, Kevin Davies, Phd, John Sterling, and Uduak Thomas for a discussion of the latest biotech and biopharma news. Listed below are links to the GEN stories referenced in this episode of Touching Base : GEN Editors Reflect on Six of the Biggest Stories of the Year By Alex Philippidis, Savannah Wiegel, Fay Lin, PhD, Kevin Davies, PhD, Uduak…
More episodes of Touching Base
- AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
- Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge
- Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers
- Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster
- AI for Scientists, FDA Reverses Course, and Advances in Cancer Therapeutics
- Women in Science, Robotics, Automation, SLAS, and Lilly Updates
Explore listener stats, chart rankings, contacts and more on the Touching Base podcast page.